Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge.

Espinosa D, Mendy J, Manayani D, Vang L, Wang C, Richard T, Guenther B, Aruri J, Avanzini J, Garduno F, Farness P, Gurwith M, Smith J, Harris E, Alexander J.

EBioMedicine. 2018 Jan;27:61-70. doi: 10.1016/j.ebiom.2017.12.010. Epub 2017 Dec 12.

2.

Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C.

Alexander J, Mendy J, Vang L, Avanzini JB, Garduno F, Manayani DJ, Ishioka G, Farness P, Ping LH, Swanstrom R, Parks R, Liao HX, Haynes BF, Montefiori DC, LaBranche C, Smith J, Gurwith M, Mayall T.

PLoS One. 2013 Dec 3;8(12):e82380. doi: 10.1371/journal.pone.0082380. eCollection 2013.

3.

Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin.

Alexander J, Ward S, Mendy J, Manayani DJ, Farness P, Avanzini JB, Guenther B, Garduno F, Jow L, Snarsky V, Ishioka G, Dong X, Vang L, Newman MJ, Mayall T.

PLoS One. 2012;7(2):e31177. doi: 10.1371/journal.pone.0031177. Epub 2012 Feb 17.

4.

Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy.

Montagna D, Maccario R, Locatelli F, Rosti V, Yang Y, Farness P, Moretta A, Comoli P, Montini E, Vitiello A.

Blood. 2001 Dec 1;98(12):3359-66.

PMID:
11719375
5.

Adoptive immunotherapy prevents prostate cancer in a transgenic animal model.

Granziero L, Krajewski S, Farness P, Yuan L, Courtney MK, Jackson MR, Peterson PA, Vitiello A.

Eur J Immunol. 1999 Apr;29(4):1127-38.

6.

Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance.

Vitiello A, Sette A, Yuan L, Farness P, Southwood S, Sidney J, Chesnut RW, Grey HM, Livingston B.

Eur J Immunol. 1997 Mar;27(3):671-8.

PMID:
9079808
7.

Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes.

Vitiello A, Yuan L, Chesnut RW, Sidney J, Southwood S, Farness P, Jackson MR, Peterson PA, Sette A.

J Immunol. 1996 Dec 15;157(12):5555-62.

PMID:
8955206
8.

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

Vitiello A, Ishioka G, Grey HM, Rose R, Farness P, LaFond R, Yuan L, Chisari FV, Furze J, Bartholomeuz R, et al.

J Clin Invest. 1995 Jan;95(1):341-9.

9.

Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules.

Sette A, Vitiello A, Farness P, Furze J, Sidney J, Claverie JM, Grey HM, Chesnut R.

J Immunol. 1991 Dec 1;147(11):3893-900.

PMID:
1658152
10.

Effects of dietary cellulose, pectin and oat bran on the small intestine in the rat.

Farness PL, Schneeman BO.

J Nutr. 1982 Jul;112(7):1315-9.

PMID:
6284891

Supplemental Content

Loading ...
Support Center